Womens Relief Balm

Description

The product is identified by the SPL code 34089-3 and consists of a combination of active and inactive ingredients. The active ingredients are not specified in the provided information. Similarly, the inactive ingredients are also not detailed. The product is formulated in a specific dosage form, which is not mentioned. The physical characteristics of the product, including appearance and other relevant attributes, are not provided.

Uses and Indications

ZEN is indicated for the relief of aches and pains associated with various conditions. This medication is particularly effective for managing discomfort related to rheumatoid arthritis, joint pain, backaches, bursitis, sore muscles, arthritis, leg cramps, and sprains and strains.

There are no teratogenic or nonteratogenic effects associated with ZEN.

Dosage and Administration

The medication should be used only as directed. It is recommended to apply a generous amount to the affected area three to four times daily. For children under the age of 12, it is essential to consult a healthcare professional prior to use to ensure safety and appropriateness of treatment.

Contraindications

Use of this product is contraindicated in situations where accidental ingestion by children may occur. To mitigate the risk of harm, it is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a poison control center is advised.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to discontinue use if excessive skin irritation develops. It is crucial to avoid contact with the eyes and mucous membranes, as this may lead to adverse effects. Additionally, patients should be instructed not to bandage the area tightly and to refrain from using the product in conjunction with a heating pad, as this may exacerbate irritation or cause other complications.

Patients should be closely monitored, and they are advised to stop use and consult a healthcare provider if any of the following occur: the condition worsens or symptoms persist for more than 7 days; symptoms resolve but then recur within a few days; or if excessive skin irritation occurs.

In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a poison control center without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. In the event of excessive skin irritation, it is advised to discontinue use immediately. Patients should also avoid contact with the eyes and mucous membranes, as this may lead to adverse reactions. It is important not to bandage the area tightly and to refrain from using the product in conjunction with a heating pad.

Participants are instructed to stop use and consult a healthcare professional if their condition worsens or if symptoms persist for more than 7 days. Additionally, if symptoms resolve and then recur within a few days, or if excessive skin irritation occurs, medical advice should be sought.

Drug Interactions

No drug interactions have been identified for the product, indicating that it does not have any known interactions with other medications. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Womens Relief Balm (camphor, eucalyptus oil, menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children to prevent accidental ingestion. In the event of swallowing the product, immediate medical assistance or contact with a poison control center is advised. For children under the age of 12, it is recommended to consult a healthcare professional prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as they may have altered pharmacokinetics and pharmacodynamics. Close monitoring is recommended to ensure safety and efficacy in this population.

Pregnancy

The product has not been evaluated for safety during pregnancy. As such, there is limited information regarding potential risks to the fetus. While no specific contraindications are mentioned, caution is advised due to the product's designation for external use only. There are no dosage modifications recommended for pregnant individuals, and no special precautions have been outlined for use during pregnancy. Healthcare professionals should consider the lack of safety data and weigh the potential benefits against any unknown risks when advising pregnant patients or women of childbearing potential.

Lactation

The safety of this product has not been established in nursing mothers. There is a potential for excretion in breast milk; therefore, caution should be exercised when administering this product to lactating mothers.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, and respiratory distress.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Additionally, it is crucial to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable. Continuous assessment and supportive measures are paramount in the management of any overdose situation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to emphasize the potential risks associated with ingestion by children.

In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a poison control center immediately. This prompt action is crucial for ensuring the safety and well-being of the patient.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light to prevent degradation. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended application of a generous amount to the affected area 3 to 4 times daily. Clinicians should advise patients to keep the product out of reach of children to prevent accidental ingestion. In the event of swallowing, patients should seek medical assistance or contact a poison control center immediately. Additionally, it is important for patients with children under 12 years of age to consult a doctor prior to use.

Drug Information (PDF)

This file contains official product information for Womens Relief Balm, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)